<DOC>
	<DOCNO>NCT01372501</DOCNO>
	<brief_summary>The purpose study determine whether GI Endobarrier Liner reimplanted .</brief_summary>
	<brief_title>Study Obese Subjects Previously Implanted With EndoBarrier Gastrointestinal Liner</brief_title>
	<detailed_description>Patients obesity significantly great risk develop significant co-morbid complication , associate increase risk all-cause mortality . The GI Endobarrier Liner represent viable alternative short-term weight loss method . It minimally invasive endoscopic procedure , may allow patient recover fast less morbidity mortality . This study investigate whether GI Endobarrier Liner reimplanted .</detailed_description>
	<criteria>Age &gt; 18 year &lt; 55 year Male Female Previously implant EndoBarrier Gastrointestinal Liner Subjects willing comply trial requirement Subjects sign informed consent form Women postmenopausal , surgically sterile oral contraceptive duration study plan become pregnant course trial . Treatment represent unreasonable risk subject Pregnant intention become pregnant duration trial Unresolved alcohol drug addiction Subjects receive weight loss medication ( prescription , overthe counter , herbal dietary medication ) Previous gastrointestinal surgery could affect ability place EndoBarrier Liner function implant . Subjects active uncontrolled gastroesophageal reflux disease ( GERD ) Subjects symptomatic kidney stone prior implant Subjects take corticosteroid drug know affect GI motility ( i.e . Reglan ) Subjects iron deficiency and/or iron deficiency anemia History Inflammatory bowel disease condition gastrointestinal tract , ulcer Crohn 's disease Subjects symptomatic gallstone prior implant Symptomatic coronary artery disease pulmonary dysfunction Known infection ( Subjects know infection time screen enrolled infection treat prior procedure ; still infection day procedure must withdraw ) History congenital acquire anomaly gastrointestinal tract atresias stenosis Pancreatitis serious organic condition Subjects require prescription anticoagulation therapy Subjects unable discontinue NSAIDs ( nonsteroidal antiinflammatory drug ) implant period Subject Family history know diagnosis preexist symptom systemic lupus erythematosus , scleroderma autoimmune connective tissue disorder Participating another ongoing investigational clinical trial Mentally retard emotionally unstable , exhibit psychological characteristic require medication affect appetite ( i.e . tricyclic antidepressant atypical antipsychotic medication ) , opinion Investigator , make subject poor candidate device placement clinical trial . Subjects active H. pylorus ( Note : Subjects may enrol prior history H. Pylori successfully treat diagnosed baseline test undergo successful treatment procedure ) Subjects history coagulopathy , upper gastrointestinal bleeding condition esophageal gastric varix , congenital acquire intestinal telangiectasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Obesity</keyword>
</DOC>